Health & Biotech
Health & Biotech
When you’re smilin’ – Wellnex to acquire premium teeth whitening brand Mr. Bright
Health & Biotech
HealthKick Podcast: PTX partners with the US’s largest cancer centre on personalised treatment
Health & Biotech
Australia’s biotech industry is thriving, with ASX-listed companies up 19% since 2019
Health & Biotech
ASX Health Stocks: Radiopharm wins US FDA Orphan status, set to accelerate treatment for rare bone cancer in kids
Health & Biotech
Prescient joins up with renowned US cancer centre in fight against blood cancer
Health & Biotech
ASX Health Stocks: Invion proves photodynamic therapy is effective against the Zika virus
Health & Biotech
IHL share price climbs before debuting on S&P/ASX 300 index
Health & Biotech
INOVIQ is carving itself a healthy share of the multi-billion dollar medical diagnostics market
Health & Biotech
Check Up: As the pandemic winds down, what’s happening with Covid focused biotechs?
Health & Biotech
PharmAust recruits first dog patient in the US, aims to close out Phase 2 canine trial faster
Health & Biotech
This ASX stock is watching you while you sleep… because it could point to Parkinson’s disease
Health & Biotech
ASX Health Stocks: China likes Uscom device, includes it in national emergency guidelines
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.